5-methyl-2-carboxamidepyrrole-based novel dual mPGES-1/sEH inhibitors as promising anticancer candidates.
Colarusso E, Lauro G, Potenza M, Galatello P, Garigliota MLD, Ferraro MG, Piccolo M, Chini MG, Irace C, Campiglia P, Hoffstetter RK, Werz O, Ramunno A, Bifulco G.
Colarusso E, et al. Among authors: bifulco g.
Arch Pharm (Weinheim). 2025 Jan;358(1):e2400708. doi: 10.1002/ardp.202400708.
Arch Pharm (Weinheim). 2025.
PMID: 39692230
Free PMC article.